RecruitingOBSERVATIONAL

Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker

This study is for people with lymphoma, pancreatic, or bowel cancer. It's looking at different ways to measure how much physical activity people do during their cancer treatment. Researchers will compare information from questionnaires, where people write down their activity, with data from motion trackers, which are small devices that measure movement. The main goal is to see if there are differences between these two ways of measuring activity and to find out which method is most accurate and helpful. Understanding this better could lead to improved ways of supporting people with cancer to stay active, which is an important part of their overall well-being and recovery.

At a glance

Status

Recruiting

Sponsor

University Medicine Greifswald

Enrolment target

Start

21 Sep 2022

Estimated completion

31 Mar 2025

Lymphoma Pancreas Cancer Colorectal Cancer

What is this study about?

When someone is going through cancer treatment, staying physically active can be really important for their health and recovery. However, it can be tricky to accurately measure how much physical activity people are actually doing. Some ways involve asking people to fill out questionnaires about their activity, while other ways use small devices, like motion trackers (a bit like a fitness watch), that automatically record movement.

This study wants to understand if these different methods give us the same information, or if one is better than the other for people with cancer. Questionnaires are easy and don't cost much, so they can be used with lots of people. Motion trackers might give a more exact measurement of movement, but they could be more complicated to use.

By comparing these two methods, the researchers hope to learn which is the best way to measure physical activity for people living with lymphoma, pancreatic cancer, or bowel cancer. The findings could help doctors and nurses better understand how active their patients are and offer more personalised advice and support to help them stay as active as possible during and after their treatment.

Key takeaways

This study compares two ways to measure physical activity: questionnaires and motion trackers.
It's for people with lymphoma, pancreatic, or bowel cancer who are having treatment.
The goal is to find the best way to understand how active cancer patients are.
No new treatments are involved; it's an 'observational' study.
Your participation could help improve future care and support for cancer patients.

Who may be eligible?

This study is open to adults aged 18 and over, and there's no upper age limit. You could be considered if you have a confirmed diagnosis of lymphoma, bowel cancer (colorectal cancer), or pancreatic cancer.

You would also need to be receiving treatment for your cancer, such as surgery, chemotherapy, or radiotherapy. Before joining, you'd need to understand what the study involves and agree to take part by giving your informed consent. This means signing a form that explains everything clearly.

However, you wouldn't be able to join if you are pregnant, or if you are unable to understand and agree to the study requirements. Also, if you regularly use a rollator (a walking frame with wheels), this study might not be suitable for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you have a diagnosis of lymphoma, pancreatic cancer, or bowel cancer?
Are you currently receiving surgery, chemotherapy, or radiotherapy for your cancer?
Are you able to understand and agree to take part in the study?
Are you not pregnant?
Do you not regularly use a rollator (walking frame with wheels)?

Answer every question to see your result.

What does participation involve?

If you join this study, it's described as an 'observational study'. This means you won't be given any new medications or treatments. Instead, the researchers will observe your usual daily activities. You would be asked to complete questionnaires about your physical activity and also wear a motion tracker device. This device will simply record your movement. The study will look at your activity at different times during your cancer treatment. The exact number of visits or the total duration isn't specified, but it's focused on gathering information about your activity over time.

Potential risks and benefits

As this is an observational study and you won't be given any new treatments, there are very few direct risks. You might find completing the questionnaires or wearing the motion tracker a minor inconvenience. The main potential benefit is that the information gathered from your participation will help researchers better understand how to measure physical activity in cancer patients. This could lead to improved support and advice for people with cancer in the future. You are free to withdraw from the study at any time without giving a reason, and this will not affect your medical care.

Locations (1)

University Medicine Greifswald
Verified postcode
Greifswald, Germany· Recruiting

Common questions

What kind of cancer patients are included?

This study is for adults with a confirmed diagnosis of lymphoma, pancreatic cancer, or bowel (colorectal) cancer who are receiving treatment.

Will I have to take any new medicines?

No, this is an 'observational' study. You won't be given any new medicines or treatments. You'll continue with your usual cancer care.

What does a 'motion tracker' do?

A motion tracker is a small device, like a fitness watch, that automatically records your physical movements throughout the day.

How often will I need to visit the clinic?

The study will involve completing questionnaires and wearing a motion tracker at different times during your treatment, but the exact number of visits isn't specified.

Why is it important to measure physical activity?

Understanding physical activity helps doctors and nurses give better advice and support to people with cancer, as being active can be an important part of recovery and well-being.

How to find out more

Ali A Aghdassi, Professor

ali.aghdassi@med.uni-greifswald.de +493834867230 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.